Centre Hospitalier De Libourne Robert Boulin

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Multiple sclerosis4 trials
• Atrial fibrillation1 trial
• Coronary artery disease1 trial
• Multiple myeloma1 trial
• Neuromyelitis optica (NMOSD)1 trial
• Stroke1 trial

Phase

• Phase 34 trials
• Phase 42 trials
• Phase 21 trial

Status

• Recruiting3 trials
• Active, not recruiting2 trials
• Not yet recruiting2 trials

Lead sponsor

• Centre Hospitalier de PAU1 trial
• Centre Hospitalier Universitaire De Nantes1 trial
• Fondation A De Rothschild1 trial
• Rennes University Hospital1 trial
• University Hospital, Montpellier1 trial
• and 2 more

Running trials

• Not yet recruiting

  Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial

  NCT07818356· Phase 4· University Hospital, Toulouse· Source

• Not yet recruiting

  Tenecteplase for the treatment of acute stroke in the late time window before inter-hospital transfer for thrombectomy: a randomized controlled trial

  2026-525280-40-00· Phase 3· Fondation A De Rothschild· Source

• Recruiting

  A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

  NCT07189325· Phase 3· University Hospital, Montpellier· Source

• Recruiting

  A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  NCT07299019· Phase 3· Zenas BioPharma (USA), LLC· Source

• Recruiting

  IFM2024-06 : A multi-center, open-label, phase 2 randomized study of elranatamab plus lenalidomide versus daratumumab plus lenalidomide as post transplantation maintenance therapy in patients with newly-diagnosed myeloma

  2024-517325-43-00· Phase 2· Centre Hospitalier Universitaire De Nantes· Source

• Active, not recruiting

  Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia

  NCT04276155· Phase 4· Centre Hospitalier de PAU· Source

• Active, not recruiting

  Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years (STOP-I-SEP)

  NCT03653273· Phase 3· Rennes University Hospital· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple sclerosis3 recruiting
• Multiple myeloma1 recruiting
• Neuromyelitis optica (NMOSD)1 recruiting
• Stroke1 recruiting